Medidata offers trial decentralization platform

By The Science Advisory Board staff writers

June 16, 2021 -- Medidata has launched an end-to-end unified platform for the decentralization of clinical trials.

The company's Decentralized Clinical Trials Program unifies direct patient data capture technology with study oversight and monitoring, offering a high level of customization and enabling fully decentralized and hybrid studies.

The program captures data remotely, then aggregates and transforms that data, monitors it to identify quality issues, and runs analytics to gain insight into better outcomes for patients, researchers, sponsors, and contract research organizations.

Medidata debuts patient engagement registries for clinical trials
Medidata has expanded its myMedidata patient portal with myMedidata Registries, a new technology designed to facilitate engagement with patients before...

Copyright © 2021

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter